Jump to navigation
The latest clinical and political news for Australian Neurologists
Its use changed diagnosis in a quarter of patients
A list of which drugs to trial first
Even mildly increased BP seems to be harmful
Two to three hours a week needed - but it must be sustained over time.
The non-surgical device is designed for treatment-resistant patients.
Phase 2 trial suggests tenecteplase may be superior
It's also linked to poor social development, a NSW study finds
Study authors call for caution among prescribers
Report identifies seven modifiable risk factors for dementia
Capsaicin triggered cerebral vasoconstriction
Multiple acute infarctions may need more intensive therapy
Seven-year olds perform poorly on educational tests.
Researchers are taking a broader look at quality-of-life.
She talks awake craniotomy and other mind-blowing aspects of medicine.
What does a new finding actually mean in real terms?
Head injury and loss of taste; Alzheimer biomarkers; Stroke research grants
Patients without Lyme can have similar symptoms, research shows.
But higher level evidence is needed, researchers say.
Changing the health service will be a challenge, he says.
Blood test reveals brain amyloid beta levels.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.